Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
7 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Bio Green Med Solution, Inc.’s names, not what it holds today.
Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
19
since 2001, to Dec 31, 2025
Names they are printed under
1
a former name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name1 counted
XCYTE Therapies, Inc. a former name
US, as the owner printed on each patent
19 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 9, 2006 | 7,041,639 | Depsipeptide and congeners thereof for use as immunosuppressants | Biotechnology | XCYTE Therapies, Inc. |
| Jun 14, 2005 | 6,905,874 | Simultaneous stimulation and concentration of cells | Biotechnology | XCYTE Therapies, Inc. |
| Mar 15, 2005 | 6,867,041 | Simultaneous stimulation and concentration of cells | Biotechnology | XCYTE Therapies, Inc. |
| Dec 7, 2004 | 6,828,302 | Therapeutic uses of depsipeptides and congeners thereof | Biotechnology | XCYTE Therapies, Inc. |
| Sep 28, 2004 | 6,797,514 | Simultaneous stimulation and concentration of cells | Biotechnology | XCYTE Therapies, Inc. |
| Apr 15, 2003 | 6,548,479 | Therapeutic uses of depsipeptides and congeners thereof | Pharmaceuticals | XCYTE Therapies, Inc. |
| Jun 11, 2002 | 6,403,555 | Depsipeptide and congeners thereof for use as immunosuppressants | Pharmaceuticals | XCYTE Therapies, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 21, 2006 | 2006/0286089 | Compositions and methods for the treatment of burns and sepsis | Medical technology | XCYTE Therapies, Inc. |
| Jun 8, 2006 | 2006/0121005 | Activation and expansion of cells | Medical technology | XCYTE Therapies, Inc. · patent 7,572,631 granted from it |
| Nov 24, 2005 | 2005/0261478 | Compositions and methods for regulating lymphocyte activation | Biotechnology | XCYTE Therapies, Inc. |
| Oct 13, 2005 | 2005/0226857 | T cell therapy for the treatment of cachexia and chronic diseases | Pharmaceuticals | XCYTE Therapies, Inc. |
| Sep 29, 2005 | 2005/0214942 | Activation and expansion of cells | Biotechnology | XCYTE Therapies, Inc. |
| Aug 4, 2005 | 2005/0171011 | Depsipeptide and congeners thereof for use as immunosuppressants | Biotechnology | XCYTE Therapies, Inc. · patent 7,041,639 granted from it |
| Jul 14, 2005 | 2005/0153447 | Activation and expansion of cells | Biotechnology | XCYTE Therapies, Inc. |
| Jun 2, 2005 | 2005/0118173 | Compositions and methods to accelerate hematologic recovery | Medical technology | XCYTE Therapies, Inc. |
| Apr 21, 2005 | 2005/0084967 | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation | Medical technology | XCYTE Therapies, Inc. |
| Dec 16, 2004 | 2004/0253250 | Compositions and methods for regulating lymphocyte activation | Biotechnology | XCYTE Therapies, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.